System Labs NAD+ review

The package is easier to picture than the outcome

System Labs presents NAD+ within a focused peptide catalog. Its treatment page describes a quarterly supply labeled 1,000 mg and a $76 first-month promotion beside a crossed-out $126 figure. ^[1] The page also explains a clinical-review pathway, included supplies and delivery. This makes the service more concrete than a generic longevity inquiry.

I would consider it for a reader who wants a home-treatment package and prefers clinician chat to organizing separate appointments. The clinical pitch is less persuasive than the logistics. A promise of better energy or focus needs its own evidence; the presence of an administration kit does not make that outcome more certain.

Injection and nasal spray require separate decisions

System’s catalog lists NAD injection and NAD nasal spray separately, while its NAD FAQ discusses both routes. ^{[1] [2]} Confirm which preparation appears in the selected quote. A quarterly quantity label should not be assumed to describe both products or every prescribed schedule.

The practical differences are substantial enough to compare explicitly. One option involves injection supplies and pharmacy handling instructions; another involves a nasal preparation. A preference about needles is relevant, but it does not resolve evidence or dosing questions. Ask the clinician to identify the proposed route and why it fits the intended purpose, then keep that product name on the payment agreement. Comparing only the general NAD heading risks buying a different service from the one you meant to assess.

Read our NAD delivery-format guide for the next part of the decision.

The first-month number is not the quarterly bill

The treatment page pairs a quarterly-supply label with a first-month promotional amount. ^[1] That leaves an important budget question: what is charged now for the selected supply and what is charged at renewal? A monthly equivalent and a monthly payment are different obligations, even when both are presented near the same treatment name.

I would not enter the crossed-out number as a guaranteed recurring cost without confirmation. Request the complete first invoice, quantity supplied, billing interval and renewal amount. If a promotion is limited to one period, make the later charge part of the comparison from the start. System’s convenience deserves a fair assessment, but a price ranking should wait until the selected agreement makes those details unambiguous.

Delivery claims should not become efficacy claims

The provider describes injections as a more direct delivery approach and promotes energy, focus and recovery. ^[1] Those claims do not establish that this home program outperforms oral NR on a meaningful clinical outcome. A route is a pharmacological distinction, rather than an automatic benefit ranking.

The published human intravenous NAD pilot examined metabolic measurements during a six-hour infusion. It did not evaluate System Labs, home subcutaneous treatment or a head-to-head supplement comparison. ^[3] I would therefore separate the attraction of avoiding an infusion appointment from a promise of equivalent or superior results. Saving time can be valuable, but it is a service advantage whose worth depends on the individual, not proof that the biological intervention delivers the advertised changes.

Read our human infusion evidence review for the next part of the decision.

Included supplies and ongoing contact are useful

System describes licensed-provider review by chat, administration supplies, ongoing clinician support and free two-day shipping. The NAD FAQ says refills are automatic and can be paused or canceled. ^[1] These details help a buyer understand what the package is intended to cover.

Before starting, establish how a clinical concern is handled and when a pause must be requested to stop the next charge or pharmacy order. Also ask which pharmacy supplies the medicine and what to do with a delivery that does not meet its handling instructions. I would count a useful follow-up arrangement as a practical strength. I would not assume that a short shipping window includes every step from intake to dispensing, or that automatic refills continue without a clinical reason.

A reasonable shortlist, after the payment terms are clear

The service fits someone comparing home NAD administration and willing to resolve the billing details before paying. It is less suitable for someone seeking a reliably demonstrated improvement in concentration or an immediately comparable flat monthly price. The focused catalog and included-kit description are real conveniences, with the clinical benefit still uncertain.

My verdict is to request one complete quote and compare it with another injection service on the same supplied period. Keep the preparation, support and renewal terms next to the price. If System makes those particulars clear, its model is straightforward to assess. If the offer remains a first-month number beside an unexplained quarterly quantity, the buying decision remains premature regardless of how attractive the promotion looks.

Read our CoreAge versus AgelessRx comparison for the next part of the decision.

Understanding the cost

The NAD+ page shows $76 for the first month beside a crossed-out $126 and a quarterly 1,000 mg supply. Confirm the actual upfront total, selected supply and renewal terms. ^[1]